OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors — ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform… CISION PRNewswireAugust 17, 2026
Press Release Kelun-Biotech Announces 2026 Interim Results CHENGDU, China, Aug. 17, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech"… CISION PRNewswireAugust 17, 2026
Thunes to Support Fiserv's Real-Time Global Payouts for Platforms Capability enables Fiserv merchant customers to offer real-time international payouts via a… CISION PRNewswireAugust 17, 2026
Press Release AiMOGA Robotics Crosses 2,000 Global Deliveries, with Robots to Serve Chery, OMODA&JAECOO, iCAUR and Lepas Showrooms across Key Destination Malaysia WUHU, China, Aug. 17, 2026 /PRNewswire/ — AiMOGA Robotics has crossed a… CISION PRNewswireAugust 17, 2026
Press Release Advancing in Solve for Tomorrow STEM Competition Samsung Malaysia Unveils Top 10 Young Innovator Teams Semi-finalists will continue their innovation journey by developing prototypes and competing for… CISION PRNewswireAugust 17, 2026
Dingdong to Report Second Quarter 2026 Financial Results on August 20, 2026 SHANGHAI, Aug. 17, 2026 /PRNewswire/ — Dingdong (Cayman) Limited ("Dingdong" or the "Company")… CISION PRNewswireAugust 17, 2026
ByteLens Turns Operator Data Into Compounding Knowledge Accelerating every operator’s journey to autonomous operations, inside their own network. AMSTERDAM,… CISION PRNewswireAugust 17, 2026
Press Release CityUHK strengthens ties with Sunway University to advance research and global education HONG KONG, Aug. 17, 2026 /PRNewswire/ — A delegation from City University… CISION PRNewswireAugust 17, 2026